Phase 2 Brain Cancer Trial, Recruiting (NCT06667726)

Phase 2 Brain Cancer Trial, Recruiting NCT06667726 Sponsor: Mayo Clinic Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06667726 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with a brain tumor
Your doctor has determined you need a special type of brain scan called an amino acid PET scan, for reasons such as planning surgery, planning radiation treatment, checking whether a tumor is growing or if it's a side effect of previous treatment, or for closer monitoring of your condition
You are able to give your own consent to participate, or you have someone who can legally give consent on your behalf

Who may not be able to join:

You are unable to have a PET scan for any reason
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06667726

Sponsor: Mayo Clinic

Phase: Phase 2

Status: Recruiting

Condition: Brain Cancer

More information: https://clinicaltrials.gov/study/NCT06667726

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with a brain tumor
Your doctor has determined you need a special type of brain scan called an amino acid PET scan, for reasons such as planning surgery, planning radiation treatment, checking whether a tumor is growing or if it's a side effect of previous treatment, or for closer monitoring of your condition
You are able to give your own consent to participate, or you have someone who can legally give consent on your behalf

Who may not be able to join:

You are unable to have a PET scan for any reason
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

24 March 2026

Est. completion

31 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Impact of 18F-DOPA PET/CT on clinical management

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov